Article citationsMore>>
Mottet, N., van den Bergh, R.C., Briers, E., Van den Broeck, T., Cumberbatch, M.G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gillessen, S., Grivas, N., Grummet, J., Henry, A.M., van der Kwast, T.H., Lam, T.B., Lardas, M., Liew, M., Mason, M.D., Moris, L. and Cornford P. (2021) EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer 2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. European Urology, 79, 243-262.
https://doi.org/10.1016/j.eururo.2020.09.042
has been cited by the following article:
-
TITLE:
Aminated Cyclopropylmethylphosphonates as Potent Prostate Cancer Inhibitors
AUTHORS:
Abed Al Aziz Al Quntar, Ibrahim Abasy
KEYWORDS:
Prostate Cancer, Cancer, Cyclopropylphophonates, Aminophosphonates, Cyclopropanes, Phosphonates, Alkynylphosphonates, Anti-Cancer, Prostate
JOURNAL NAME:
Journal of Biosciences and Medicines,
Vol.12 No.7,
July
23,
2024
ABSTRACT: Inspired by the anti-pancreatic promising results of our novel aminated cyclopropylmethylphosphonate compounds, an in vitro anti-prostate cancer activity exploration of these compounds was carried out on human prostate cancer cell line PC-3, and showed potent inhibiting activity at low micromolar concentrations (with an IC50 of approximately 45 μM).
Related Articles:
-
Ananda Prasad Panta, Ram Prasad Ghimire, Dinesh Panthi, Shankar Raj Pant
-
Minzhi Wei, Yujian Gan, Shengqiang Tang
-
Md. Mamun-Ur-Rashid Khan
-
Baoxing Li, Xiaojun Ren, Xiao Zhang, Zhiwei Ma, Jiaojiao Gu, Guobao Li
-
A. Tsoumou, M. Mikia, I. Mady-Goma Dirat, D. B. C. Olabi-Obath, H. Banga-Mboko, J. Vouidibio